The association between IL1RAP expression and AML patient survival and response to hematopoietic stem cell transplantation (HSCT) was next examined, as FLT3-ITD mutations have been reported to associate with decreased overall survival in NPM1-mutated/DNMT3 A-mutated AML [8]. This evidence concerns the gene IL1RAP and acute myeloid leukemia.